The path to true transparency

  • August 7, 2019
Sameer Awsare, MD, FACP, focuses on government rules and state laws attempting to hold pharmaceutical companies accountable to escalating prescription drug prices, and asks what's true transparency?
Read More

The price is wrong

  • February 19, 2019
Sameer Awsare, MD, associate executive director at The Permanente Medical Group, addresses the need to curb prices on biologics to protect patients.
Read More

Sameer Awsare, MD, Addresses Rising Drug Prices

  • March 2, 2017

Sameer Awsare, MD, associate executive director of The Permanente Medical Group, spoke at last fall’s Southern California edition of the State of Reform Health Policy Conference, drawing attention to the growing problem of rising drug prices. The State of Reform…

Read More